Skip to main content

NIH Issues Request for SBIR/STTR Applications

NEW YORK (GenomeWeb News) – The National Institutes of Health on Friday issued requests for applications for two trans-NIH funding programs for small businesses focused on bioscience and biomedicine, including the Small Business Innovation Research grants and the Small Business Technology Transfer program.

The STTR grants will give either up to $100,000 (Phase I) for one year or $750,000 (Phase II) for up to two years.

The SBIR grants will provide either up to $100,000 (Phase I) for a period of up to six months or up to $750,000 (Phase II) for a period of no more than two years.

The STTR program is aimed at using federal funds to stimulate "a partnership of ideas and technologies between innovative small business concerns and non-profit institutions," and to assist small businesses and research communities in commercializing innovative technologies, according to NIH.

The SBIR program is focused on several goals, including: stimulating technological innovation in the private sector; strengthening the role of small business in meeting federal R&D needs; increasing commercial applications of federally-supported research; fostering participation by socially and economically disadvantaged and women-owned small business concerns; improving the return on investment from federally-funded research.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.